Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma

NCT02400242 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

85

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy

Conditions

Multiple Myeloma

Interventions

DRUG: ACY-241
DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

Celgene